How are you?Thank you for visiting NKGEN.

• Since its establishment in 2016, NK immune cell technology company has been a bio-venture company focusing on research and product development of anti-cancer immunotherapy drugs such as special culture solution manufacturing and cell storage projects for immune cell treatment.
• NKGEN has a technology to improve the immune system in the body by collecting NK cells of patients during chemotherapy, cultivating them in large quantities in vitro, and injecting them again.
• We are in the process of establishing a GMP (Good Manufacturing Practice) facility in 2022. In addition, we are constantly striving and growing by promoting listings such as consultations on selecting preliminary organizations for listing on the KOSDAQ. All executives and employees of NKGEN promise to do their best to overcome the health of the people and cancer of mankind.
• Thank you.